The global Oncology Companion Diagnostics Market, which was valued at USD 2.48 Billion in 2020, is projected to grow at a compound annual growth rate (CAGR) of 13% throughout the forecast period. Factors such as the increasing prevalence of cancer worldwide, the expanding application of companion diagnostics, and the growing significance of oncology companion diagnostics in next-generation omics are expected to contribute to the growth of market revenue.

https://www.reportsanddata.com/report-detail/oncology-companion-diagnostics-market